AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
🔥 Spotify Founder's Longevity Startup: Bear v Bull Case (Neko Health)
Big Picture Medicine
The Bull Case for Biomarkers
$200 is actually a low price range for all of the biomarkers that you get. If they can attract a segment of the population that won't already have been going through like annual physical exams, then that's where the winning part is. So what's the bull case here? Why is this going to be a huge thing that disrupts the market? The issue is not the tech, because we already have these tests. But the problem is how do you bring in new people? That's it.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode